Linked Data API

Show Search Form

Search Results

1146250
star this property registered interest false more like this
star this property date less than 2019-09-25more like thismore than 2019-09-25
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medical Treatments: Nanotechnology more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the Prime Minister's speech to the UN on 24 September 2019, what assessment he has made of the regulatory framework for the use of nanotechnology in medicine. more like this
star this property tabling member constituency Newcastle upon Tyne Central remove filter
star this property tabling member printed
Chi Onwurah remove filter
unstar this property uin 291007 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer remove filter
star this property answer text <p>Currently nanotechnology used in medicine is regulated under the legislation that applies to medical devices and medicinal products.</p><p>The medical device regulations require that all medical devices are safe and perform as intended. The regulations have recently been updated and the new regulations include specific requirements for medical devices containing nanomaterials. This means that any medical device containing nanomaterials will be subject to more detailed regulatory scrutiny than under the current regulations.</p><p>As with all medicinal products, before a nanomedicine is granted a marketing authorisation and becomes available in the United Kingdom, it must be fully evaluated in relation to the appropriate standards required in the relevant legislation on medicinal products. In addition, specific scientific guidelines on nanomedicines have been developed to help medicines developers prepare marketing authorisation applications for nanomedicines.</p><p>No specific assessment of the regulatory framework for the use of nanotechnology in medicine has been undertaken.</p><p> </p>
star this property answering member constituency Mid Bedfordshire more like this
star this property answering member printed Ms Nadine Dorries more like this
star this property question first answered
less than 2019-09-30T12:03:27.607Zmore like thismore than 2019-09-30T12:03:27.607Z
star this property answering member
1481
star this property label Biography information for Ms Nadine Dorries more like this
unstar this property tabling member
4124
unstar this property label Biography information for Chi Onwurah more like this